John Libbey Eurotext

Journal de Pharmacie Clinique

MENU

Comparison and practical guidelines of selective serotonin reuptake inhibitors Volume 21, issue 1, Mars 2002

Figures

See all figures

Authors
Pharmacie de l'hôpital Haut-Lévêque, avenue de Magellan, 33600 Pessac.

Depression is a recurrent and often chronic disorder, sometimes resistant. It is a major health problem. The selective serotonin reuptake inhibitors (SSRIs) are the most used products among the antidepressants. All the SSRIs have a great selectivity for serotonin reuptake, sertralin is the most powerful, citalopram the most selective; on monoamine receptors, slight differences exist. On pharmacokinetic plane, the most differences are observed on the metabolism. Except for a longer delay of action with fluoxetine vs others SSRIs, no difference was reported in the overall efficacy and tolerability. Despite a large homogeneity, practical guidelines can be overviewed.